Cannita, K., Paradisi, S., Cocciolone, V., Bafile, A., Rinaldi, L., Irelli, A., . . . Ficorella, C. (2016). New schedule of bevacizumab/paclitaxel as first‐line therapy for metastatic HER2‐negative breast cancer in a real‐life setting. Cancer Med.
Styl ChicagoCannita, Katia, et al. "New Schedule of Bevacizumab/paclitaxel As First‐line Therapy for Metastatic HER2‐negative Breast Cancer in a Real‐life Setting." Cancer Med 2016.
Citace podle MLACannita, Katia, et al. "New Schedule of Bevacizumab/paclitaxel As First‐line Therapy for Metastatic HER2‐negative Breast Cancer in a Real‐life Setting." Cancer Med 2016.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..